Highlights of Ending Age-Related Diseases 2020
Key points from 20 presentations from world-leading researchers
Join the club for FREE to access the whole archive and other member benefits.
Professor of Bioengineering at Berkeley University of California.
Irina Conboy got her PhD. in Pat Jones laboratory at Department of Biological Sciences at Stanford University, in Molecular and Cellular Immunology.
She specialised in degenerative diseases, exemplified by Parkinson’s, Alzheimer’s, metabolic disorders, osteoporosis, and muscle atrophy, in which the bodies capacity to regenerate new tissue can no longer keep up with tissue death invariably accompany human aging. These disorders are debilitating for individuals and represent a major problem for society. One intriguing possibility is that stem cells residing in aged organs retain their intrinsic ability to regenerate but are not properly triggered in the aged environment and that rejuvenation of the aged niches is actually required for the organ repair by any stem cell: endogenous or transplanted. Much of our work has been focused on establishing new paradigms in multi-tissue stem cell aging, rejuvenation and regulation by conserved morphogenic signaling pathways.
Visit website: https://vcresearch.berkeley.edu/faculty/irina-conboy
See also:
University of California, Berkeley
- Public land-grant research university
Part of a series organized by SENS Research Foundation's Education Department
06-Sep-2023 to 08-Sep-2023
Jointly organised with the Biochemical Society - researcher disciplines include biochemistry, biology and medicine
Live Longer World podcast #9 with Dr. Irina & Michael Conboy as guests
19-Aug-2021 to 22-Aug-2021
Hear the latest developments from the leading experts in rejuvenation biotechnology research
11-Aug-2022 to 14-Aug-2022
Virtual Conference for Rejuvenation Biotechnology and Life Extension organized by Lifespan Extension Advocacy Foundation
Key points from 20 presentations from world-leading researchers
Mary Ann Liebert, Inc. - 04-Aug-2022
Infusions of young blood plasma into mice, does not increase their lifespan
Read more...Live Forever Club - 20-Aug-2021
Very much looking forward to seeing published results on initial human pilot
Read more...Longevity Technology - 29-Apr-2021
"Very promising" results from pilot study, with phase 3 clinical trial planned
Read more...Live Forever Club - 27-Jan-2021
Conboys are planning a modified lifespan study - looking for funding
Read more...Lifespan.io (LEAF) - 22-Dec-2020
Results aren't published in any journal but might be the first step towards more human studies
Read more...Heales - 22-Dec-2020
Many people were disappointed that Katcher didn't report lifespan impact - this is about to change
Read more...Lifespan.io (LEAF) - 17-Nov-2020
Reduces neuroinflammation & promotes neurogenesis in aged brains of mice
Read more...Lifespan.io (LEAF) - 16-Jun-2020
This could be a cheap first generation rejuvenation treatment - but wait for clinical trials
Read more...Aging Matters - 08-Jun-2020
There are things in blood that drives our ageing
Read more...Lifespan.io (LEAF) - 03-Sep-2019
Adjusting the levels of just two molecules in the blood could lead to significant rejuvenation
Read more...Bioengineer.org - 25-Mar-2019
Could reduce time and cost of DNA testing
Read more...Lifespan.io (LEAF) - 18-Jan-2018
Interview with Dr. Irina Conboy of Berkeley University. Youthful TGF-?1 signaling in old mice ca...
Read more...Josh Mitteldorf Blog - 23-Jan-2017
Mix of proteins in your blood is characteristic of your age. Might rejuvenation be achieved by a...
Read more...Dan’s Plan - 20-Jan-2017
Interview with Drs. Michael and Irina Conboy of the Department of Bioengineering at UC Berkeley. ...
Read more...Lifespan.io (LEAF) - 18-Jan-2017
Attempts have been made to rejuvenate the body by transfusing old people with young blood. Recen...
Read more...Guardian - 22-Nov-2016
Participants will have their blood passed through a machine that resets abnormal levels of protei...
Read more...